Pfizer
Prithvi Shankar possesses extensive experience in the pharmaceutical and digital compliance sectors, currently serving as Sr. Manager of Digital Compliance & Regulatory Risk Management at Pfizer since June 2011, focusing on supply chain and manufacturing digital solutions. Previous roles include Domain Consultant at Wipro Ltd and Associate Consultant at Cognizant Technology Solutions, alongside significant production management experience at The Himalaya Drug Company. Earlier career highlights include positions as Executive-Production at Caryl Pharma and Production Chemist at Juggat Pharma, where Prithvi managed various production processes for pharmaceutical products. Prithvi holds an Executive MBA from the Indian Institute of Management, Calcutta, and a Bachelor of Pharmacy from Al-Ameen College of Pharmacy.
This person is not in any teams
This person is not in any offices
Pfizer
616 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.